The Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act would set a $98 floor for Medicare reimbursement for the dual-energy X-ray absorptiometry (DXA) bone density test.
Town Hall Provides Tools to Guide Patients Unsure About COVID-19 Vaccination
The ACR’s May 13 virtual town hall highlighted effective approaches rheumatology providers can take to convince patients to be vaccinated against COVID-19.
Higher Risk of Adverse Events When Biologic Infusions Are Done at Home
(Reuters Health)—Patients who receive biologic infusions at home may have a higher risk of adverse events than those who receive the infusions at a health care facility, a new study suggests.1 Researchers examined administrative claims data on 57,220 adults who received a total of 752,150 biologic infusions for immune-mediated disease between 2007 and 2017. The…
Platelets: An Underrecognized Piece of the Lupus Puzzle
Platelets may be a key source of mitochondrial antigens in systemic lupus erythematosus, according to a recent study.
Relative Value Survey Forthcoming for Updated AMA Outpatient Consultation Codes
Some ACR members will be randomly selected to take an important survey to determine relative values for services in new outpatient consultation codes.
Improving Seniors’ Timely Access to Care Act Reintroduced in House
The Improving Seniors’ Timely Access to Care Act (H.R. 3173) will require the Centers for Medicare & Medicaid Services to regulate the use of prior authorization by Medicare Advantage plans and establish a process to make real-time decisions for services that are routinely approved. Ask your Congressperson today to support providers and patients and join the more than 100 representatives who are co-sponsoring the bill.
Medicare Contractors Provide Guidance for Use of JA, JB Modifiers
As of April 2021, Medicare requires the use of the JA or JB modifier when billing for drugs that have one Healthcare Common Procedure Coding System Level II (J or Q) code but multiple routes of administration.
Cohort Study Reveals Patients Treated with Rituximab Have Poorer COVID-19 Outcomes
According to a recent cohort study, patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab therapy experience more severe COVID-19. Researchers also found an association between rituximab use and prolonged hospital stays.
Add-On Voclosporin Improves Outcomes in Lupus Nephritis
NEW YORK (Reuters Health)—Voclosporin (Lupkynis) in combination with mycophenolate mofetil (MMF) and low-dose corticosteroids improves renal response rates compared with use of these agents alone in patients with in lupus nephritis, according to a company-funded study. “Lupus nephritis can be a devastating condition if not diagnosed and managed early. These data establish voclosporin as an…
New French Law Extends Benefits to Families of Healthcare Workers Who Contracted COVID-19 & Died During the Pandemic
According to the French newspaper, Le Monde, the French Assembly adopted the “mort pour le service de la République”—died in the service of the Republic—statute on May 27. President Emmanuel Macron says this new law is one way to support the families of personnel who die under exceptional circumstances, such as healthcare providers who died…
- « Previous Page
- 1
- …
- 70
- 71
- 72
- 73
- 74
- …
- 325
- Next Page »